DNA Brands Cash And Equivalents vs. Total Debt

DNAX Stock  USD 0.0002  0.0001  100.00%   
Based on DNA Brands' profitability indicators, DNA Brands may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess DNA Brands' ability to earn profits and add value for shareholders.
For DNA Brands profitability analysis, we use financial ratios and fundamental drivers that measure the ability of DNA Brands to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well DNA Brands utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between DNA Brands's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of DNA Brands over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
Please note, there is a significant difference between DNA Brands' value and its price as these two are different measures arrived at by different means. Investors typically determine if DNA Brands is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DNA Brands' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

DNA Brands Total Debt vs. Cash And Equivalents Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining DNA Brands's current stock value. Our valuation model uses many indicators to compare DNA Brands value to that of its competitors to determine the firm's financial worth.
DNA Brands is rated below average in cash and equivalents category among its peers. It is rated # 5 in total debt category among its peers making up about  4,008  of Total Debt per Cash And Equivalents. Comparative valuation analysis is a catch-all model that can be used if you cannot value DNA Brands by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for DNA Brands' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

DNA Total Debt vs. Cash And Equivalents

Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

DNA Brands

Cash

 = 

Bank Deposits

+

Liquidities

 = 
499
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

DNA Brands

Total Debt

 = 

Bonds

+

Notes

 = 
M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

DNA Total Debt vs Competition

DNA Brands is rated # 5 in total debt category among its peers. Total debt of Consumer Staples industry is currently estimated at about 14.92 Billion. DNA Brands adds roughly 2 Million in total debt claiming only tiny portion of stocks in Consumer Staples industry.
Total debt  Capitalization  Valuation  Revenue  Workforce

DNA Brands Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in DNA Brands, profitability is also one of the essential criteria for including it into their portfolios because, without profit, DNA Brands will eventually generate negative long term returns. The profitability progress is the general direction of DNA Brands' change in net profit over the period of time. It can combine multiple indicators of DNA Brands, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
It offers products in various flavors, such as cellular citrus zero sugar, cellular citrus, cryo berry, and molecular melon. DNA Brands, Inc. also owns TokenTalk.io, an advisory firm for companies looking to raise money through an ICO. Dna Brands operates under BeveragesNon-Alcoholic classification in the United States and is traded on OTC Exchange. It employs 1 people.

DNA Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on DNA Brands. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of DNA Brands position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the DNA Brands' important profitability drivers and their relationship over time.

Use DNA Brands in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DNA Brands position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DNA Brands will appreciate offsetting losses from the drop in the long position's value.

DNA Brands Pair Trading

DNA Brands Pair Trading Analysis

The ability to find closely correlated positions to DNA Brands could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DNA Brands when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DNA Brands - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DNA Brands to buy it.
The correlation of DNA Brands is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DNA Brands moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DNA Brands moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DNA Brands can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your DNA Brands position

In addition to having DNA Brands in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Agriculture Thematic Idea Now

Agriculture
Agriculture Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Agriculture theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Agriculture Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for DNA Pink Sheet Analysis

When running DNA Brands' price analysis, check to measure DNA Brands' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNA Brands is operating at the current time. Most of DNA Brands' value examination focuses on studying past and present price action to predict the probability of DNA Brands' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNA Brands' price. Additionally, you may evaluate how the addition of DNA Brands to your portfolios can decrease your overall portfolio volatility.